Nintx (Next Innovative Therapeutics), a startup created in Brazil, aims to decode complex biological interactions to bring the next generation of therapies

Recent advances in science and technology and their intersection with biological diversity can exponentialize the development of breakthrough therapies

Recent advances in science, technologies and their intersection with biological diversity offer a unique opportunity to interpret interspecies molecular crosstalk and exponentialize the development of breakthrough therapies. In this context, Nintx (Next Innovative Therapeutics) originates in Brazil, which has the greatest biological diversity on the planet, as a startup founded by Dr. Miller Nunes de Freitas. and Dr. Cristiano R. W. Guimaraes. Nintx (www.nintx.com.br) will decode complex biological interactions to bring the next generation of therapies for global unmet medical needs.

To have access to the full content, check us out on LinkedIn.

https://www.linkedin.com/feed/update/urn:li:activity:6798360788332490752/